Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gala Beykin

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Ophthalmology Reports|November 2, 2020
Molecular Biomarkers for GlaucomaGala Beykin, Jeffrey L Goldberg
The British Journal of Ophthalmology|October 29, 2013
Paediatric and adolescent elevated conjunctival lesions in the plical area: lymphoma or reactive lymphoid hyperplasia?Gala Beykin, Jacob Pe'er, Gail Amir, et al.
The British Journal of Ophthalmology|September 26, 2013
Pars plana vitrectomy to repair retinal detachment following brachytherapy for uveal melanomaGala Beykin, Jacob Pe'er, Yitzchak Hemo, et al.
The British Journal of Ophthalmology|June 4, 2021
Long-term outcome of neovascular age-related macular degeneration: association between treatment outcome and major risk allelesBrice Nguedia Vofo, Gala Beykin, Jaime Levy, et al.
The British Journal of Ophthalmology|February 28, 2014
Authors' response: Pars planavitrectomy to repair retinal detachment following brachytherapy for uveal melanomaGala Beykin, Jacob Pe'er, Yitzchak Hemo, et al.
BMC Ophthalmology|April 17, 2015
Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: "real life" long-term outcomeGala Beykin, Michelle Grunin, Edward Averbukh, et al.
Progress in Retinal and Eye Research|July 14, 2020
Discovery and clinical translation of novel glaucoma biomarkersGala Beykin, Anthony M Norcia, Vivek J Srinivasan, et al.
European Journal of Ophthalmology|May 5, 2020
Socioeconomic status and visual outcome in patients with neovascular age-related macular degenerationNadav Levinger, Gala Beykin, Michelle Grunin, et al.
Ophthalmology Science|May 17, 2023
Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma: Safety, Neuroprotection, and NeuroenhancementJeffrey L Goldberg, Gala Beykin, Kellie R Satterfield, et al.
BMC Ophthalmology|December 20, 2025
Virtual reality stimulation for neuroprotection and neuroenhancement of vision in optic neuropathy patients: a prospective clinical trialKatherine J Healzer, Tasneem Z Khatib, Gala Beykin, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Ophthalmology Reports|November 2, 2020
Molecular Biomarkers for GlaucomaGala Beykin, Jeffrey L Goldberg
The British Journal of Ophthalmology|October 29, 2013
Paediatric and adolescent elevated conjunctival lesions in the plical area: lymphoma or reactive lymphoid hyperplasia?Gala Beykin, Jacob Pe'er, Gail Amir, et al.
The British Journal of Ophthalmology|September 26, 2013
Pars plana vitrectomy to repair retinal detachment following brachytherapy for uveal melanomaGala Beykin, Jacob Pe'er, Yitzchak Hemo, et al.
The British Journal of Ophthalmology|June 4, 2021
Long-term outcome of neovascular age-related macular degeneration: association between treatment outcome and major risk allelesBrice Nguedia Vofo, Gala Beykin, Jaime Levy, et al.
The British Journal of Ophthalmology|February 28, 2014
Authors' response: Pars planavitrectomy to repair retinal detachment following brachytherapy for uveal melanomaGala Beykin, Jacob Pe'er, Yitzchak Hemo, et al.
BMC Ophthalmology|April 17, 2015
Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: "real life" long-term outcomeGala Beykin, Michelle Grunin, Edward Averbukh, et al.
Progress in Retinal and Eye Research|July 14, 2020
Discovery and clinical translation of novel glaucoma biomarkersGala Beykin, Anthony M Norcia, Vivek J Srinivasan, et al.
European Journal of Ophthalmology|May 5, 2020
Socioeconomic status and visual outcome in patients with neovascular age-related macular degenerationNadav Levinger, Gala Beykin, Michelle Grunin, et al.
Ophthalmology Science|May 17, 2023
Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma: Safety, Neuroprotection, and NeuroenhancementJeffrey L Goldberg, Gala Beykin, Kellie R Satterfield, et al.
BMC Ophthalmology|December 20, 2025
Virtual reality stimulation for neuroprotection and neuroenhancement of vision in optic neuropathy patients: a prospective clinical trialKatherine J Healzer, Tasneem Z Khatib, Gala Beykin, et al.
Pageof 2